siRNA Technology in Kidney Transplantation: Current Status and Future Potential

[1]  J. Kamps,et al.  Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[2]  J. Kellum,et al.  Current Use of Biomarkers in Acute Kidney Injury: Report and Summary of Recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference , 2013, Kidney international.

[3]  B. Sis,et al.  Advances in the understanding of transplant glomerulopathy. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  C. Nguan,et al.  Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model. , 2013, American journal of physiology. Renal physiology.

[5]  Bin Yang,et al.  Naked caspase 3 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. , 2013, The Journal of surgical research.

[6]  R. Manfro,et al.  Expression of fibrosis-related genes in human renal allografts with interstitial fibrosis and tubular atrophy. , 2013, Journal of nephrology.

[7]  C. Vanhove,et al.  In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. , 2013, Biomaterials.

[8]  R. Smith,et al.  Targeting complement at the time of transplantation. , 2013, Advances in experimental medicine and biology.

[9]  J. Chapman.  Do protocol transplant biopsies improve kidney transplant outcomes? , 2012, Current opinion in nephrology and hypertension.

[10]  So-Young Lee,et al.  Distinct pathophysiologic mechanisms of septic acute kidney injury: Role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury , 2012, Critical care medicine.

[11]  Li Li,et al.  Inhibition of PAX2 Gene Expression by siRNA (Polyethylenimine) in Experimental Model of Obstructive Nephropathy , 2012, Renal failure.

[12]  M. Yanagita.  Inhibitors/antagonists of TGF-β system in kidney fibrosis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  B. Molitoris,et al.  Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration. , 2012, Nucleic acid therapeutics.

[14]  A. Baranova,et al.  Therapeutic siRNAs and nonviral systems for their delivery , 2012, Molecular Biology.

[15]  A. Marakhonov,et al.  [Types of non-viral delivery systems of small interfering RNA]. , 2012, Molekuliarnaia biologiia.

[16]  A. Jevnikar,et al.  Use of RNA interference to minimize ischemia reperfusion injury. , 2012, Transplantation reviews.

[17]  K. Brown,et al.  Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. , 2012, Journal of the American Society of Nephrology : JASN.

[18]  R. Marcén,et al.  Immunosuppressive Drugs in Kidney Transplantation , 2009, Drugs.

[19]  M. Soltani,et al.  Nonviral approach for targeted nucleic acid delivery. , 2012, Current medicinal chemistry.

[20]  J. Torras,et al.  In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection , 2011, Gene Therapy.

[21]  H. Schnaper,et al.  Tubulointerstitial injury and the progression of chronic kidney disease , 2011, Pediatric Nephrology.

[22]  J. Burnett,et al.  Current progress of siRNA/shRNA therapeutics in clinical trials , 2011, Biotechnology journal.

[23]  G. Glazko,et al.  Network biology: a direct approach to study biological function , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[24]  L. V. van Heurn,et al.  Preservation techniques for donors after cardiac death kidneys , 2011, Current opinion in organ transplantation.

[25]  Bin Yang,et al.  Naked Small Interfering RNA of Caspase-3 in Preservation Solution and Autologous Blood Perfusate Protects Isolated Ischemic Porcine Kidneys , 2011, Transplantation.

[26]  P. He,et al.  Biological Effects of Lentivirus-Mediated shRNA Targeting Collagen Type I on the Mesangial Cells of Rats , 2011, Renal failure.

[27]  J. E. Murray.  Ronald Lee Herrick Memorial:June 15, 1931–December 27, 2010 , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  R. Stratta,et al.  Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post‐transplant outcomes , 2011, Clinical transplantation.

[29]  Xiao-hou Wu,et al.  Transforming growth factor-β1 short hairpin RNA inhibits renal allograft fibrosis. , 2011, Chinese medical journal.

[30]  Xin Chen,et al.  Small interfering RNA targeting IKKβ prevents renal ischemia-reperfusion injury in rats. , 2011, American journal of physiology. Renal physiology.

[31]  L. Racusen,et al.  The pathology of chronic allograft dysfunction. , 2010, Kidney international. Supplement.

[32]  B. Molitoris,et al.  Intravital Two-Photon Microscopy Assessment of Renal Protection Efficacy of siRNA for p53 in Experimental Rat Kidney Transplantation Models , 2010, Cell transplantation.

[33]  S. P. Walton.  Engineering active siRNA therapeutics. , 2010, The FEBS journal.

[34]  R. Henning,et al.  Towards graft-specific immune suppression: Gene therapy of the transplanted kidney. , 2010, Advanced drug delivery reviews.

[35]  P. Hamar,et al.  Application of siRNA in targeting protein expression in kidney disease. , 2010, Advanced drug delivery reviews.

[36]  M. Okusa,et al.  Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. , 2010, Seminars in nephrology.

[37]  W. Buurman,et al.  Biological modulation of renal ischemia–reperfusion injury , 2010, Current opinion in organ transplantation.

[38]  N. Nishiyama,et al.  siRNA-based therapy ameliorates glomerulonephritis. , 2010, Journal of the American Society of Nephrology : JASN.

[39]  K. Karwacz,et al.  HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7 , 2010, Journal of Virology.

[40]  C. Alpers,et al.  Novel siRNA Delivery System to Target Podocytes In Vivo , 2010, PloS one.

[41]  M. Bucher,et al.  Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. , 2010, American journal of physiology. Renal physiology.

[42]  M. T. Grande,et al.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy , 2010, Journal of Inflammation.

[43]  F. Strutz.  Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction , 2009, Clinical transplantation.

[44]  B. Molitoris,et al.  siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.

[45]  J. Bonventre,et al.  Early effects of brain death on kidney injury and outcome after transplantation , 2010 .

[46]  A. Butte,et al.  Expression of complement components differs between kidney allografts from living and deceased donors. , 2009, Journal of the American Society of Nephrology : JASN.

[47]  Y. Takakura,et al.  Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. , 2009, Advanced drug delivery reviews.

[48]  T. Ichim,et al.  Small Interfering RNA Targeting RelB Protects Against Renal Ischemia-reperfusion Injury , 2009, Transplantation.

[49]  K. Miyamoto,et al.  SHARP-2 Gene Silencing by Lentiviral-based Short Hairpin RNA Interference Prolonged Rat Kidney Transplant Recipients' Survival Time , 2009, The Journal of international medical research.

[50]  M. Stegall,et al.  Identifying Specific Causes of Kidney Allograft Loss , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[51]  R. Formica,et al.  Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  Y. Isaka,et al.  In vivo transfer of small interfering RNA or small hairpin RNA targeting glomeruli. , 2009, Methods in molecular biology.

[53]  W. Rowiński,et al.  Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. , 2008, Transplantation proceedings.

[54]  Motohiko Suzuki,et al.  Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. , 2008, The American journal of pathology.

[55]  Y. Lu,et al.  Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy. , 2008, Transplantation proceedings.

[56]  R. Henning,et al.  Immune modulation and graft protection by gene therapy in kidney transplantation. , 2008, European journal of pharmacology.

[57]  I. Stillman,et al.  Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. , 2008, Journal of the American Society of Nephrology : JASN.

[58]  A. Jevnikar,et al.  Late kidney allograft loss: what we know about it, and what we can do about it. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[59]  P. Chiarella,et al.  Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. , 2008, Expert opinion on biological therapy.

[60]  H. Kawachi,et al.  Chemically modified siRNA prolonged RNA interference in renal disease. , 2007, Biochemical and biophysical research communications.

[61]  M. Sherif,et al.  Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. , 2007, The Cochrane database of systematic reviews.

[62]  D. Lewis,et al.  Systemic siRNA delivery via hydrodynamic intravascular injection. , 2007, Advanced drug delivery reviews.

[63]  T. Paavonen,et al.  Clinical Predictors of Renal Allograft Histopathology: A Comparative Study of Single-Lesion Histology Versus a Composite, Quantitative Scoring System , 2007, Transplantation.

[64]  Motohiko Suzuki,et al.  Protection of Renal Ischemia Injury using Combination Gene Silencing of Complement 3 and Caspase 3 Genes , 2006, Transplantation.

[65]  Motohiko Suzuki,et al.  Prevention of Renal Ischemic Injury by Silencing the Expression of Renal Caspase 3 and Caspase 8 , 2006, Transplantation.

[66]  Y. Isaka.  Gene therapy targeting kidney diseases: routes and vehicles , 2006, Clinical and Experimental Nephrology.

[67]  M. Nicholson,et al.  The aetiology and pathogenesis of chronic allograft nephropathy. , 2006, Transplant immunology.

[68]  A. Jevnikar,et al.  Increasing Resistance of Tubular Epithelial Cells to Apoptosis by shRNA Therapy Ameliorates Renal Ischemia‐Reperfusion Injury , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[69]  A. Jevnikar,et al.  Preventing Renal Ischemia–Reperfusion Injury Using Small Interfering RNA by Targeting Complement 3 Gene , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[70]  Young-Chae Chang,et al.  TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. , 2006, Experimental and molecular pathology.

[71]  O. Boerman,et al.  INTRAVENOUSLY ADMINISTERED SHORT INTERFERING RNA ACCUMULATES IN THE KIDNEY AND SELECTIVELY SUPPRESSES GENE FUNCTION IN RENAL PROXIMAL TUBULES , 2006, Drug Metabolism and Disposition.

[72]  H. Volk,et al.  TGF-β1 mRNA upregulation influences chronic renal allograft dysfunction , 2006 .

[73]  P. Boros,et al.  New Cellular and Molecular Immune Pathways in Ischemia/Reperfusion Injury , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  Y. Tabata,et al.  Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[75]  H. Volk,et al.  TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. , 2006, Kidney international.

[76]  J. Chapman,et al.  Chronic renal allograft dysfunction. , 2005, Journal of the American Society of Nephrology : JASN.

[77]  Manabu Kinoshita,et al.  A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. , 2005, Biochemical and biophysical research communications.

[78]  Y. Tabata,et al.  Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[79]  H. Kawachi,et al.  Exploring RNA interference as a therapeutic strategy for renal disease , 2005, Gene Therapy.

[80]  J. Thurman,et al.  Acute tubular necrosis is characterized by activation of the alternative pathway of complement. , 2005, Kidney international.

[81]  Giuseppe Remuzzi,et al.  Delayed graft function in kidney transplantation , 2004, The Lancet.

[82]  J. Lieberman,et al.  Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S J White,et al.  Promoters and control elements: designing expression cassettes for gene therapy. , 2004, Current gene therapy.

[84]  M. Weisfeldt,et al.  Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. , 2003, American journal of physiology. Renal physiology.

[85]  H. Rabb,et al.  The role of adhesion molecules and T cells in ischemic renal injury , 2003, Current opinion in nephrology and hypertension.

[86]  Thomas Tuschl,et al.  Expanding small RNA interference , 2002, Nature Biotechnology.

[87]  Q. Al-Awqati,et al.  Stem cells in the kidney. , 2002, Kidney international.

[88]  J. Jenkins,et al.  Mechanism and prevention of cold storage-induced human renal tubular cell injury. , 2000, Transplantation.

[89]  B. Kasiske,et al.  Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[90]  K. Abe,et al.  In situ localization of C3 synthesis in experimental acute renal allograft rejection. , 2000, The American journal of pathology.

[91]  M. Kuske,et al.  Assignment1 of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping , 2000, Cytogenetic and Genome Research.

[92]  J. Lemasters,et al.  Reperfusion injury after liver preservation for transplantation. , 1997, Annual review of pharmacology and toxicology.

[93]  K. Lemley,et al.  Structure of the glomerular mesangium: a biomechanical interpretation. , 1990, Kidney international. Supplement.

[94]  J E Saffitz,et al.  Pathophysiology of myocardial reperfusion. , 1985, Annual review of medicine.